Development of hypoxia-activated PROTAC exerting a more potent effect in tumor hypoxia than in normoxia
in hypoxia than in normoxia in HCC4006 cells. This is the first example of identifying a PROTAC to selectively act on tumors utilizing the characteristic of tumor hypoxia and provides a new approach for PROTAC development.
